Oculis SA’s securing a CHF 15.5 Million financing round

Paolo Bossi

The Tekla Funds (Healthcare, Life Sciences) invested in Oculis SA as part of a CHF 15.5 equity financing round. Oculis SA is biopharmaceutical Swiss Startup company…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here